FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/07/2023
Voltar para busca
Dado oficial do USPTO
MICROBULB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
04/07/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
22/09/2021
Data de registro
07/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/03/2023
Última transação
07/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BLANE, SUZANNE
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LightBio Limited
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Nucleic acid comprising natural and unnatural nucleotides for scientific and research purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for scientific and research purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for scientific and research purposes; all the aforesaid goods for use in nanotechnology applications in the nature of data storagedata retrieval and computing for scientific and research purposes; nucleic acids or nucleic acid analogues for labellingimaging and sensing applications for scientific and research purposes; nucleic acids or nucleic acid analogues as smart materials in the nature of smart therapeutic reagents and assays for scientific and research purposes; two-dimensional and three-dimensional nucleic acids or nucleic acid analogues for creating nanostructures and scaffolds for scientific and research purposes; chemical preparationsenzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in scientific research in the field of agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials in the nature of smart therapeutic reagents and assays; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds
Classe 5
Vaccines; DNA based vaccines; DNA extractsnucleic acid sequences and chemical reagents for medical use; therapeutic DNAnucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials in the nature of smart therapeutic reagents and assays; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
Classe 9
Electronic componentsnucleic acid analogues in the nature of electric wiressemi-conductorstransistorsrectifiersdiodeslight emitting diodes and energy storage systems in the nature of batteries and electrochemical devices configured for energy storagenamely electrolysersall comprising nucleic acids or nucleic acid analogues; parts and fittings for all the aforesaid technology and parts and fitting for all the aforesaid goodselectrical cablesdisplay screenstransmitters
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/06/2023
FIMP
FINAL DISPOSITION PROCESSED
11/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2023
GPNX
NOTIFICATION PROCESSED BY IB
21/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/12/2022
PUBO
PUBLISHED FOR OPPOSITION
20/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/11/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/10/2022
RFNT
REFUSAL PROCESSED BY IB
17/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/07/2022
RFRR
REFUSAL PROCESSED BY MPU
25/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/06/2022
CNRT
NON-FINAL ACTION WRITTEN
27/06/2022
DOCK
ASSIGNED TO EXAMINER
24/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
22/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/02/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/02/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MICROBULB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.